Literature DB >> 6372096

Structure and expression of a complementary DNA for the nuclear coded precursor of human mitochondrial ornithine transcarbamylase.

A L Horwich, W A Fenton, K R Williams, F Kalousek, J P Kraus, R F Doolittle, W Konigsberg, L E Rosenberg.   

Abstract

Most mitochondrial proteins are encoded in the nucleus and are translated on free cytoplasmic ribosomes as larger precursors containing amino-terminal "leader" sequences, which are removed after the precursors are taken up by mitochondria. We have deduced the complete primary structure of the precursor of a human mitochondrial matrix enzyme, ornithine transcarbamylase (OTC), from the nucleotide sequence of cloned complementary DNA. The amino-terminal leader peptide of OTC is 32 amino acids in length and contains four arginines but no acidic residues. Cleavage of the leader peptide from the "mature" protein occurs between glutamine and asparagine residues. The sequence of mature human OTC resembles that of the subunits of both OTC and aspartate transcarbamylase from Escherichia coli. The biological activity of the cloned OTC complementary DNA was tested by joining it with SV40 (an animal virus) regulatory elements and transfecting cultured HeLa cells, which do not normally express OTC. Both the precursor and mature forms of the OTC subunit were identified; in stable transformants, enzymatic activity was also detected.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372096     DOI: 10.1126/science.6372096

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  97 in total

1.  Immunological characterization of plant ornithine transcarbamylases.

Authors:  R D Slocum; C L Williamson; C A Poggenburg; M A Lynes
Journal:  Plant Physiol       Date:  1990       Impact factor: 8.340

2.  Substrate-induced conformational change in a trimeric ornithine transcarbamoylase.

Authors:  Y Ha; M T McCann; M Tuchman; N M Allewell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Origin, structure, and regulation of argK, encoding the phaseolotoxin-resistant ornithine carbamoyltransferase in Pseudomonas syringae pv. phaseolicola, and functional expression of argK in transgenic tobacco.

Authors:  E Hatziloukas; N J Panopoulos
Journal:  J Bacteriol       Date:  1992-09       Impact factor: 3.490

4.  Protein folding in the cell: an inside story.

Authors:  Arthur L Horwich
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

5.  Ornithine transcarbamylase polymorphism detected by PCR introduction of DraI site.

Authors:  E M Petty; R Carstens; A E Bale
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

6.  Survey of amino-terminal proteolytic cleavage sites in mitochondrial precursor proteins: leader peptides cleaved by two matrix proteases share a three-amino acid motif.

Authors:  J P Hendrick; P E Hodges; L E Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells.

Authors:  J T Lee; R L Nussbaum
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

8.  Arginine in the leader peptide is required for both import and proteolytic cleavage of a mitochondrial precursor.

Authors:  A L Horwich; F Kalousek; L E Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases.

Authors:  P Seibel; J Trappe; G Villani; T Klopstock; S Papa; H Reichmann
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

10.  Specificity of PCR-SSCP for detection of the mutant ornithine transcarbamylase (OTC) gene in patients with OTC deficiency.

Authors:  R Hoshide; T Matsuura; S Komaki; E Koike; I Ueno; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.